Psychiatric care in prison: Quasi-experimental evaluation of treatment on the general psychiatric ward in Neumünster prison

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00037612

Enrollment

Registered

2025-08-26

Start date

2025-01-01

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F00-F99

Interventions

Group 1: Intervention group: Sequentially admitted male prisoners, that receive treatment as usual on the general psychiatric ward in Neumünster prison (Treatment weekly includes: 1 contact with a doc

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Patient on the psychiatric ward (intervention group) or prisoner, sentenced or on remand, on another ward (control group), in Neumünster Prison

Exclusion criteria

Exclusion criteria: - Lack of language skills - Intellectual disability - Severe mental symptoms (e. g. acute suicidality, florid psychosis) where self-report is unreliable or contraindicated - Remaining prison sentence < 6 weeks

Design outcomes

Primary

Measure	Time frame
Self-report questionnaires at the time of admission/start of study participation (T1) and after 6 weeks (T6W). For the patient group, if T6W ? time of treatment termination, questionnaires are also surveyed exploratively at time of treatment termination (T2). Outcome measures are: 1) Psychological symptoms, measured through Symptom Checklist 90 Revised (SCL-90-R) 2) General treatment outcome (symptoms, functioning, well-being, risk of self-harm or harming others), measured through Clinical Outcomes in Routine Evaluations - Outcome Measure (CORE-OM) 3) Quality of life, measured through EUROHIS Quality of Life Index (EUROHIS-QoL)	—

Measure

Time frame

Self-report questionnaires at the time of admission/start of study participation (T1) and after 6 weeks (T6W). For the patient group, if T6W ? time of treatment termination, questionnaires are also surveyed exploratively at time of treatment termination (T2). Outcome measures are: 1) Psychological symptoms, measured through Symptom Checklist 90 Revised (SCL-90-R) 2) General treatment outcome (symptoms, functioning, well-being, risk of self-harm or harming others), measured through Clinical Outcomes in Routine Evaluations - Outcome Measure (CORE-OM) 3) Quality of life, measured through EUROHIS Quality of Life Index (EUROHIS-QoL)

—

Countries

Germany

Contacts

Public ContactChristian Huchzermeier

Institut für Sexualmedizin und Forensische Psychiatrie und Psychotherapie

christian.huchzermeier@uksh.de+49 431 500 98600

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026